Latest news |
|
Special Issue (Ongoing): Heart disease and stroke Edited by Prof. Yuchuan Ding, Prof. Jawahar L. Mehta, and Prof. Simon W Rabkin
Guest Editor:
Prof. Yuchuan Ding, M.D., Ph.D., Professor
Wayne State University School of Medicine, USA
Prof. Yuchuan Ding is Vice Chair for Research, Director of Cerebrovascular Research, Department of Neurosurgery, Wayne State University School of Medicine. He is nationally and internationally renowned as an expert in stroke therapy, traumatic brain injury and thermal injury research.
Guest Editor:
Prof. Jawahar L. Mehta, M.D., Ph.D., Professor
University of Arkansas for Medical Sciences, USA
Prof. Mehta is known for his original work on platelet biology and thrombosis in myocardial ischemia. Dr. Mehta's latest research has focused on the biology of LOX-1, a receptor for oxidized low density lipoprotein. He serves or has served on the editorial boards of several major cardiology, physiology, and pharmacology journals, including Circulation, Hypertension, American Journal of Cardiology, European Heart Journal, and the Journal of the American College of Cardiology.
Guest Editor:
Prof. Simon W Rabkin M.D., FRCPC, FESC, FACC,
Professor
University of British Columbia, Canada
Dr Simon Rabkin is a Professor of Medicine in the Division of Cardiology at the University of British Columbia (UBC). He graduated with an MD from the University of Manitoba. He did post graduate training in Internal Medicine and Cardiology at the University of Toronto, University of Cincinnati and Emory University. His research interests are in the determinants of cardiovascular disease and its therapy.
According to the World Health Organization (WHO), the worldwide leading cause of death in 2019 was ischemic heart disease at 8.9 million and the second leading cause of death was stroke at 6.1 million. The inextricable links between heart disease and stroke are well known, as the stroke and heart disease frequently coexist and the mortality rate is as high as 54%. In addition, cardiovascular disease, such as atrial fibrillation and heart failure, may worsen the outcome and functional consequences of stroke.
We aim to ameliorate the worldwide impact of heart disease and stroke through the prevention of common risk factors, including high blood pressure, high cholesterol, diabetes, smoking, obesity, unhealthy diet, physical inactivity, and mental stress. We hope to reduce health disparities through improvements in health outcomes across geographic, racial, ethnic, and socioeconomic groups. These efforts will help lower adverse events and death rates from heart disease and stroke.
This Special Issue will comprehensively explore the prevention, diagnosis, treatment, outcome of heart disease and stroke, especially the interaction between them. The publications in this issue will inspire physicians and researchers searching for strategies to better the lives of patients with these two conditions.
|
